51 results
Keyword Aimovig Remove keyword
-
List item
Committee for Medicinal Products for Human Use (CHMP): 19-22 April 2021
European Medicines Agency, Amsterdam, the Netherlands, from 19/04/2021 to 22/04/2021, Last updated: 07/12/2021 -
List item
Committee for Medicinal Products for Human Use (CHMP): 22-25 February 2021
European Medicines Agency, Amsterdam, the Netherlands, from 22/02/2021 to 25/02/2021, Last updated: 07/12/2021 -
List item
Download medicine data
Last updated: 02/12/2021 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28 November - 1 December 2022
PRAC, Last updated: 02/12/2022 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 2-5 May 2022
PRAC, Last updated: 06/05/2022 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 3-6 May 2021
PRAC, Last updated: 07/05/2021 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10 - 13 January 2022
PRAC, Last updated: 14/01/2022– VYEPTI, erenumab – AIMOVIG (CAP), fremanezumab – AJOVY … -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 10-12 May 2023
European Medicines Agency, Amsterdam, the Netherlands, from 10/05/2023 to 12/05/2023, Last updated: 18/08/2021 -
List item
Committee for Medicinal Products for Human Use (CHMP): 21-24 June 2021
European Medicines Agency, Amsterdam, the Netherlands, from 21/06/2021 to 24/06/2021, Last updated: 07/12/2021 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 6-9 April 2021
PRAC, Last updated: 09/04/2021 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 11-14 January 2021
PRAC, Last updated: 15/01/2021 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 February 2021
PRAC, Last updated: 12/02/2021 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 7-10 June 2021
PRAC, Last updated: 11/06/2021 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 29 November - 2 December 2021
PRAC, Last updated: 03/12/2021 -
List item
Annual reports and work programmes (updated)
Last updated: 15/05/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 28-31 May 2018
European Medicines Agency, London, UK, from 28/05/2018 to 31/05/2018, Last updated: 06/01/2014 -
List item
Committee for Medicinal Products for Human Use (CHMP): 25-29 January 2021
Virtual meeting, from 25/01/2021 to 29/01/2021, Last updated: 04/03/2021 -
List item
Committee for Medicinal Products for Human Use (CHMP): 19-22 July 2021
European Medicines Agency, Amsterdam, the Netherlands, from 19/07/2021 to 22/07/2021, Last updated: 07/10/2021 -
List item
Newsletter archive
Last updated: 20/10/2015 -
List item
Committee for Medicinal Products for Human Use (CHMP): 12-15 December 2022
European Medicines Agency, Amsterdam, the Netherlands, from 12/12/2022 to 15/12/2022, Last updated: 06/04/2021 -
List item
Committee for Medicinal Products for Human Use (CHMP): 13-16 September 2021
European Medicines Agency, Amsterdam, the Netherlands, from 13/09/2021 to 16/09/2021, Last updated: 04/11/2019 -
List item
Public data from Article 57 database
Last updated: 17/10/2022 -
List item
Committee for Medicinal Products for Human Use (CHMP): 25-28 June 2018
European Medicines Agency, London, UK, from 25/06/2018 to 28/06/2018, Last updated: 06/01/2014 -
List item
News: Annual report 2020 published
Last updated: 14/06/2021 -
List item
News: EMA publishes annual report 2021
Last updated: 10/06/2022